Correlation Between Neoleukin Therapeutics and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and C4 Therapeutics, you can compare the effects of market volatilities on Neoleukin Therapeutics and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and C4 Therapeutics.
Diversification Opportunities for Neoleukin Therapeutics and C4 Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Neoleukin and CCCC is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and C4 Therapeutics
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to under-perform the C4 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Neoleukin Therapeutics is 2.18 times less risky than C4 Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The C4 Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 348.00 in C4 Therapeutics on September 1, 2024 and sell it today you would earn a total of 107.00 from holding C4 Therapeutics or generate 30.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 8.33% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. C4 Therapeutics
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| C4 Therapeutics |
Neoleukin Therapeutics and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and C4 Therapeutics
The main advantage of trading using opposite Neoleukin Therapeutics and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |